NPI: 1295726032 · BIRMINGHAM, AL 35233 · Clinical Medical Laboratory · NPI assigned 11/01/2005
Authorized official WILLIAMS, KIMBERLY controls 20+ related entities in our dataset. Read more
| Authorized Official | WILLIAMS, KIMBERLY (VP) |
| NPI Enumeration Date | 11/01/2005 |
Other providers sharing the same authorized official: WILLIAMS, KIMBERLY
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 3,195,249 | $31.05M |
| 2019 | 3,318,726 | $30.51M |
| 2020 | 3,792,306 | $38.15M |
| 2021 | 4,811,560 | $47.94M |
| 2022 | 4,776,272 | $47.46M |
| 2023 | 5,408,181 | $51.78M |
| 2024 | 4,360,273 | $42.22M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1,060,905 | 926,649 | $21.16M |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1,053,401 | 920,094 | $20.59M |
| 80050 | General health panel | 789,061 | 696,368 | $16.70M |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 738,701 | 655,136 | $12.54M |
| 81420 | Fetal chromosomal aneuploidy genomic sequence analysis panel | 42,226 | 36,376 | $11.71M |
| 80061 | Lipid panel | 1,768,106 | 1,538,467 | $11.33M |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 852,597 | 723,068 | $11.29M |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 738,246 | 657,202 | $10.34M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 129,095 | 113,563 | $8.91M |
| 80053 | Comprehensive metabolic panel | 1,654,006 | 1,445,431 | $8.70M |
| 80081 | 162,952 | 147,553 | $7.12M | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 483,727 | 443,938 | $7.12M |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 147,327 | 137,257 | $6.73M |
| 84443 | Thyroid stimulating hormone (TSH) | 874,088 | 760,912 | $6.50M |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1,464,954 | 1,273,313 | $6.45M |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 168,852 | 143,130 | $5.48M |
| 83036 | Hemoglobin; glycosylated (A1C) | 1,279,116 | 1,095,496 | $5.39M |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | 23,266 | 17,762 | $4.91M |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 259,385 | 236,674 | $4.37M |
| 87086 | Culture, bacterial; quantitative colony count, urine | 840,820 | 745,399 | $3.81M |
| 80074 | 164,586 | 136,544 | $3.02M | |
| 86803 | 387,761 | 341,069 | $2.92M | |
| 87536 | 62,332 | 56,344 | $2.69M | |
| 84439 | 640,037 | 552,898 | $2.54M | |
| 82607 | 351,100 | 299,674 | $2.46M | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 53,957 | 45,305 | $2.41M |
| 87150 | 140,121 | 128,311 | $2.32M | |
| 86480 | 54,972 | 48,013 | $1.77M | |
| 84403 | 133,629 | 116,534 | $1.72M | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 90,041 | 77,301 | $1.70M |
| 86235 | 32,698 | 28,648 | $1.65M | |
| 82746 | 237,249 | 203,288 | $1.53M | |
| 86592 | 611,710 | 545,386 | $1.50M | |
| 87081 | 348,300 | 323,882 | $1.47M | |
| 82728 | 252,911 | 216,971 | $1.45M | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 33,887 | 28,582 | $1.44M |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 29,189 | 25,286 | $1.43M |
| 80055 | 34,695 | 29,638 | $1.36M | |
| 86696 | 114,018 | 101,476 | $1.26M | |
| 87088 | 276,428 | 249,442 | $1.22M | |
| 87186 | 237,695 | 215,708 | $1.16M | |
| 82670 | 84,085 | 73,427 | $1.15M | |
| 84153 | 136,606 | 115,670 | $1.13M | |
| 84702 | 159,390 | 117,624 | $1.08M | |
| 83001 | 108,929 | 96,646 | $1.07M | |
| 83655 | 125,350 | 116,435 | $1.07M | |
| 87340 | 189,869 | 168,458 | $1.07M | |
| 87077 | 236,067 | 214,489 | $1.02M | |
| 84146 | 97,141 | 85,308 | $1.01M | |
| 83550 | 242,022 | 207,730 | $967K | |
| 88142 | 63,216 | 58,598 | $884K | |
| 86360 | 37,478 | 32,845 | $880K | |
| 88141 | 74,415 | 67,878 | $878K | |
| 87522 | Neg quan hep c or qual rna | 41,607 | 36,761 | $876K |
| 86003 | 27,132 | 21,499 | $859K | |
| 83002 | 88,462 | 78,367 | $858K | |
| 84402 | 68,088 | 59,234 | $851K | |
| 36415 | Collection of venous blood by venipuncture | 505,878 | 441,711 | $788K |
| 87902 | 7,102 | 6,072 | $786K | |
| 83970 | 49,553 | 42,387 | $784K | |
| 82570 | 285,584 | 251,989 | $783K | |
| 83540 | 281,715 | 241,424 | $777K | |
| 86038 | 115,511 | 102,134 | $754K | |
| 85027 | 256,063 | 223,668 | $747K | |
| 86769 | 20,832 | 15,902 | $735K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 176,276 | 154,113 | $714K |
| 86695 | 100,938 | 89,906 | $708K | |
| 84481 | 96,675 | 84,023 | $704K | |
| 82043 | 252,648 | 224,893 | $694K | |
| 84144 | 65,124 | 54,061 | $679K | |
| 84436 | 216,502 | 187,263 | $627K | |
| 83013 | 19,343 | 17,692 | $622K | |
| 87070 | 119,470 | 109,662 | $616K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 32,240 | 14,665 | $602K |
| 82950 | 191,625 | 175,035 | $601K | |
| 86780 | 72,755 | 65,478 | $590K | |
| 81001 | 314,955 | 273,607 | $544K | |
| 86762 | 62,133 | 54,472 | $524K | |
| 82784 | 65,789 | 57,369 | $523K | |
| 83735 | 153,387 | 128,988 | $518K | |
| 83880 | 35,190 | 29,444 | $512K | |
| 86850 | 82,240 | 72,411 | $472K | |
| 86376 | 64,318 | 56,030 | $458K | |
| 86140 | 169,858 | 148,333 | $415K | |
| 86787 | 51,431 | 45,563 | $412K | |
| 87901 | 3,283 | 2,956 | $411K | |
| 84479 | 161,533 | 139,597 | $409K | |
| 86706 | 70,055 | 60,828 | $396K | |
| 84480 | 58,933 | 51,893 | $392K | |
| 86665 | 19,003 | 17,208 | $383K | |
| 83525 | 60,838 | 52,812 | $381K | |
| 83516 | 31,205 | 27,032 | $369K | |
| 81329 | 14,638 | 11,322 | $349K | |
| 86677 | 25,326 | 21,700 | $338K | |
| 86361 | 26,813 | 23,579 | $329K | |
| 86704 | 54,060 | 46,841 | $327K | |
| 84550 | 136,603 | 119,904 | $327K | |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | 6,885 | 5,756 | $325K |
| 82627 | 26,699 | 23,400 | $315K | |
| 83021 | 26,676 | 23,907 | $315K | |
| 83020 | 41,675 | 37,317 | $314K | |
| 82951 | 41,633 | 38,376 | $310K | |
| 87625 | 16,520 | 14,768 | $310K | |
| 85660 | 85,224 | 76,219 | $305K | |
| 86147 | 9,324 | 7,980 | $283K | |
| 80164 | 44,738 | 38,049 | $283K | |
| 87900 | 4,126 | 3,653 | $269K | |
| 83498 | 21,241 | 18,722 | $265K | |
| 86160 | 22,215 | 19,165 | $253K | |
| 85652 | 169,872 | 148,491 | $253K | |
| 86364 | 29,572 | 25,276 | $250K | |
| 86225 | 35,972 | 31,462 | $246K | |
| 83690 | 64,998 | 57,070 | $243K | |
| 86431 | 83,086 | 73,716 | $235K | |
| 86708 | 34,342 | 29,494 | $216K | |
| 82947 | 102,397 | 88,596 | $215K | |
| 87480 | 20,410 | 17,634 | $215K | |
| 80076 | 52,994 | 47,488 | $212K | |
| 87075 | 40,622 | 37,287 | $210K | |
| 87510 | 20,378 | 17,603 | $210K | |
| 82248 | 79,682 | 68,511 | $207K | |
| 87660 | 19,940 | 17,598 | $206K | |
| 84270 | 21,459 | 18,602 | $205K | |
| 86800 | 28,389 | 24,818 | $205K | |
| 82105 | 29,631 | 25,419 | $201K | |
| 82150 | 57,750 | 50,200 | $200K | |
| 84681 | 23,842 | 20,936 | $193K | |
| 82274 | 20,533 | 18,527 | $189K | |
| 86870 | 12,638 | 11,257 | $187K | |
| 85610 | 95,907 | 77,450 | $186K | |
| 84450 | 80,639 | 69,947 | $181K | |
| 82565 | 83,051 | 70,908 | $181K | |
| 82785 | 23,816 | 20,148 | $180K | |
| 87209 | 17,369 | 15,768 | $175K | |
| 86258 | 16,538 | 13,739 | $170K | |
| 86200 | 28,060 | 24,571 | $168K | |
| 80069 | 42,117 | 36,131 | $168K | |
| 82533 | 19,013 | 16,283 | $162K | |
| 84156 | 81,080 | 69,548 | $160K | |
| 84460 | 63,807 | 55,777 | $159K | |
| 81257 | 4,519 | 3,392 | $157K | |
| 87906 | 2,347 | 2,102 | $156K | |
| 86356 | 4,951 | 4,040 | $155K | |
| 85018 | 89,598 | 82,475 | $153K | |
| 82977 | 51,296 | 44,170 | $150K | |
| 83615 | 51,531 | 44,451 | $146K | |
| 81596 | 6,469 | 5,746 | $144K | |
| 86664 | 15,728 | 14,344 | $143K | |
| 85730 | 54,842 | 45,372 | $143K | |
| 87255 | 8,963 | 8,308 | $142K | |
| 82550 | 40,605 | 35,425 | $140K | |
| 85045 | 64,204 | 55,211 | $138K | |
| 87529 | 7,585 | 6,396 | $133K | |
| 86141 | 24,750 | 21,099 | $132K | |
| 82247 | 61,255 | 51,978 | $132K | |
| 86317 | 15,815 | 13,880 | $132K | |
| 86901 | 64,930 | 57,041 | $129K | |
| 82024 | 6,406 | 5,612 | $124K | |
| 84520 | 68,881 | 58,487 | $122K | |
| 86231 | 20,537 | 17,160 | $120K | |
| 86900 | 64,844 | 56,933 | $117K | |
| 87535 | 8,154 | 7,036 | $116K | |
| 85014 | 63,949 | 58,961 | $115K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 1,024 | 959 | $110K |
| 81361 | 4,532 | 3,400 | $110K | |
| 81003 | 83,366 | 71,717 | $105K | |
| 86593 | 43,090 | 37,983 | $105K | |
| 84703 | 24,767 | 21,800 | $105K | |
| 84075 | 55,807 | 47,862 | $104K | |
| 84100 | 54,330 | 44,440 | $103K | |
| 82040 | 55,544 | 47,531 | $101K | |
| 84425 | 10,880 | 9,319 | $99K | |
| 87427 | 15,067 | 13,956 | $99K | |
| 87517 | 4,572 | 4,124 | $98K | |
| 86255 | 17,078 | 15,161 | $98K | |
| 86146 | 4,050 | 3,207 | $97K | |
| 82672 | 9,594 | 8,390 | $95K | |
| 82652 | 8,826 | 6,624 | $94K | |
| 82952 | 38,803 | 35,804 | $93K | |
| 82310 | 50,341 | 43,160 | $93K | |
| 86359 | 5,576 | 4,752 | $91K | |
| 84295 | 45,180 | 38,477 | $89K | |
| 86618 | 9,517 | 8,280 | $89K | |
| 84155 | 55,053 | 47,400 | $88K | |
| 87177 | 17,513 | 15,912 | $85K | |
| 87045 | 15,039 | 13,936 | $81K | |
| 86735 | 11,278 | 9,780 | $80K | |
| 84132 | 38,929 | 33,438 | $80K | |
| 86765 | 11,644 | 10,131 | $80K | |
| 86709 | 13,757 | 11,681 | $79K | |
| 84445 | 4,147 | 3,704 | $79K | |
| 82435 | 44,406 | 37,834 | $76K | |
| 84154 | 9,778 | 8,364 | $75K | |
| 84165 | 15,285 | 13,487 | $75K | |
| 86008 | 10,217 | 8,502 | $72K | |
| 81479 | Unlisted molecular pathology procedure | 1,789 | 1,312 | $72K |
| 86334 | 7,768 | 6,874 | $70K | |
| 87521 | Neg quan hep c or qual rna | 3,787 | 3,453 | $68K |
| 88342 | 1,963 | 1,650 | $67K | |
| 82378 | 9,148 | 7,544 | $66K | |
| 80178 | 20,132 | 16,910 | $65K | |
| 86702 | 10,780 | 9,309 | $63K | |
| 85384 | 15,430 | 13,509 | $63K | |
| 80185 | 9,912 | 8,471 | $62K | |
| 83704 | 9,102 | 7,560 | $61K | |
| 84466 | 10,999 | 9,503 | $58K | |
| 80051 | 19,468 | 16,642 | $58K | |
| 87046 | 15,234 | 14,020 | $57K | |
| 86757 | 5,428 | 4,679 | $57K | |
| 82465 | 23,425 | 21,038 | $55K | |
| 86663 | 6,791 | 6,206 | $55K | |
| 86341 | 4,353 | 3,760 | $54K | |
| 81243 | 8,783 | 6,791 | $54K | |
| 87563 | 3,319 | 2,943 | $54K | |
| 84305 | 5,562 | 4,923 | $53K | |
| 86705 | 7,543 | 6,687 | $51K | |
| 82626 | 4,093 | 3,616 | $51K | |
| 86645 | 5,586 | 5,025 | $51K | |
| 82677 | 4,501 | 3,926 | $51K | |
| 88112 | 1,659 | 1,412 | $51K | |
| 82140 | 7,744 | 6,674 | $51K | |
| 87324 | 8,142 | 7,343 | $50K | |
| 81374 | 3,467 | 2,996 | $50K | |
| 86694 | 6,238 | 5,543 | $50K | |
| 85379 | 9,853 | 8,456 | $49K | |
| 81255 | 4,540 | 3,400 | $49K | |
| 86644 | 6,287 | 5,611 | $49K | |
| 80177 | 9,782 | 8,697 | $49K | |
| 83520 | 7,748 | 6,713 | $49K | |
| 81251 | 4,535 | 3,395 | $48K | |
| 86300 | 4,162 | 3,548 | $48K | |
| 82103 | 7,714 | 6,651 | $47K | |
| 84207 | 4,424 | 3,725 | $46K | |
| 87650 | 3,954 | 3,733 | $46K | |
| 87184 | 9,945 | 9,189 | $45K | |
| 83090 | 7,137 | 5,724 | $44K | |
| 81200 | 4,533 | 3,395 | $44K | |
| 86304 | 9,314 | 7,675 | $44K | |
| 81330 | 4,534 | 3,395 | $43K | |
| 87350 | 7,208 | 6,256 | $42K | |
| 80197 | 9,195 | 6,294 | $42K | |
| 86777 | 5,280 | 4,664 | $42K | |
| 86701 | 10,372 | 8,950 | $41K | |
| 82397 | 7,505 | 6,352 | $41K | |
| 84134 | 7,464 | 6,200 | $41K | |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 1,242 | 1,061 | $40K |
| 81260 | 4,538 | 3,398 | $40K | |
| 80348 | 9,910 | 9,402 | $40K | |
| 82390 | 7,620 | 6,591 | $39K | |
| 82239 | 4,383 | 3,521 | $39K | |
| 85041 | 16,988 | 15,456 | $38K | |
| 80156 | 6,299 | 5,463 | $38K | |
| 81290 | 4,533 | 3,395 | $38K | |
| 82330 | 8,190 | 7,127 | $38K | |
| 82088 | 2,018 | 1,758 | $37K | |
| 86060 | 8,675 | 7,862 | $37K | |
| 81242 | 4,541 | 3,400 | $37K | |
| 81209 | 4,541 | 3,398 | $36K | |
| 86707 | 5,947 | 5,188 | $36K | |
| 87329 | 5,221 | 4,717 | $35K | |
| 83721 | 9,755 | 8,631 | $35K | |
| 80299 | 1,982 | 1,597 | $34K | |
| 81025 | 9,040 | 7,946 | $34K | |
| 88307 | 288 | 258 | $33K | |
| 88312 | 1,133 | 947 | $33K | |
| 85048 | 18,690 | 16,825 | $33K | |
| 86336 | 4,541 | 3,972 | $33K | |
| 83718 | 7,210 | 6,621 | $32K | |
| 86381 | 3,448 | 2,872 | $31K | |
| 88304 | 1,661 | 1,410 | $30K | |
| 87493 | 2,616 | 2,391 | $30K | |
| 87101 | 6,456 | 5,824 | $30K | |
| 80361 | 10,639 | 9,982 | $29K | |
| 82985 | 3,608 | 3,307 | $28K | |
| 86256 | 3,629 | 2,892 | $28K | |
| 84484 | 4,872 | 4,271 | $28K | |
| 84432 | 3,460 | 3,071 | $27K | |
| 84166 | 3,758 | 3,278 | $26K | |
| 82575 | 4,430 | 4,068 | $26K | |
| 80349 | 2,065 | 1,876 | $26K | |
| 86301 | 3,994 | 3,138 | $25K | |
| 83521 | 2,466 | 2,139 | $25K | |
| 82553 | 3,684 | 3,230 | $24K | |
| 83921 | 3,202 | 2,797 | $23K | |
| 80365 | 10,247 | 9,730 | $23K | |
| 82374 | 13,319 | 11,421 | $23K | |
| 87040 | 3,797 | 3,327 | $22K | |
| 82731 | 538 | 483 | $22K | |
| 83010 | 3,843 | 3,334 | $22K | |
| 87338 | 3,319 | 3,057 | $22K | |
| 82166 | 1,423 | 1,155 | $22K | |
| 83883 | 4,521 | 3,981 | $21K | |
| 82787 | 1,679 | 1,484 | $20K | |
| 87109 | 3,106 | 2,880 | $20K | |
| 82157 | 1,317 | 1,112 | $20K | |
| 80346 | 2,221 | 2,081 | $20K | |
| 84244 | 1,957 | 1,725 | $20K | |
| 86778 | 2,594 | 2,315 | $20K | |
| 87538 | 1,568 | 1,341 | $19K | |
| 85060 | 5,777 | 5,037 | $19K | |
| 82104 | 3,068 | 2,644 | $19K | |
| 80159 | 2,974 | 2,257 | $19K | |
| 80353 | 10,202 | 9,566 | $19K | |
| 83993 | 2,205 | 1,965 | $18K | |
| 84478 | 7,464 | 6,212 | $18K | |
| 86308 | 5,541 | 5,038 | $18K | |
| 84482 | 3,946 | 3,173 | $18K | |
| 84630 | 3,829 | 3,213 | $18K | |
| 80184 | 3,679 | 3,073 | $18K | |
| 85598 | 2,504 | 2,052 | $18K | |
| 85613 | 3,779 | 3,126 | $17K | |
| 87799 | 2,069 | 1,473 | $17K | |
| 86015 | 3,666 | 3,111 | $17K | |
| 80183 | 3,459 | 3,135 | $17K | |
| 85004 | 4,525 | 3,834 | $17K | |
| 82525 | 3,529 | 2,896 | $17K | |
| 84999 | 3,069 | 2,776 | $17K | |
| 80373 | 9,708 | 9,219 | $17K | |
| 80358 | 9,746 | 9,255 | $16K | |
| 85246 | 1,309 | 1,175 | $16K | |
| 87205 | 7,686 | 6,817 | $16K | |
| 85240 | 1,619 | 1,422 | $16K | |
| 82164 | 2,682 | 2,301 | $16K | |
| 80345 | 1,459 | 1,385 | $16K | |
| 86337 | 1,502 | 1,314 | $15K | |
| 80165 | 2,651 | 2,305 | $15K | |
| 82747 | 2,333 | 1,929 | $15K | |
| 81422 | 897 | 703 | $14K | |
| 86671 | 1,772 | 1,519 | $14K | |
| 86617 | 1,417 | 1,164 | $14K | |
| 80359 | 9,741 | 9,252 | $14K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 493 | 405 | $14K |
| 85007 | 8,832 | 7,466 | $13K | |
| 86037 | 1,561 | 1,260 | $13K | |
| 85245 | 1,028 | 925 | $13K | |
| 86335 | 1,868 | 1,589 | $13K | |
| G0307 | Complete (cbc), automated (hgb, hct, rbc, wbc; without platelet count) | 9,052 | 7,837 | $12K |
| 81241 | 1,624 | 1,226 | $12K | |
| 80175 | 2,847 | 2,554 | $12K | |
| 80354 | 9,280 | 8,806 | $12K | |
| 84080 | 2,187 | 1,900 | $12K | |
| 88230 | 254 | 227 | $12K | |
| 88262 | 226 | 203 | $12K | |
| 85597 | 1,633 | 1,350 | $12K | |
| G0475 | Hiv antigen/antibody, combination assay, screening | 4,889 | 4,148 | $11K |
| 89055 | 4,829 | 4,438 | $11K | |
| 84590 | 2,340 | 1,909 | $11K | |
| 80162 | 2,517 | 2,142 | $11K | |
| 81291 | 1,375 | 1,081 | $10K | |
| 83789 | 968 | 840 | $10K | |
| 86666 | 989 | 837 | $10K | |
| 81377 | 255 | 174 | $10K | |
| 85306 | 1,153 | 939 | $10K | |
| 81381 | 1,868 | 1,500 | $10K | |
| 87076 | 1,990 | 1,856 | $10K | |
| 82955 | 1,896 | 1,682 | $10K | |
| 87206 | 3,468 | 3,078 | $10K | |
| 82679 | 829 | 710 | $9K | |
| 88341 | 184 | 162 | $9K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 481 | 462 | $9K |
| 83992 | 6,173 | 5,857 | $9K | |
| 80372 | 8,797 | 8,331 | $9K | |
| 87210 | 2,961 | 2,669 | $8K | |
| 80324 | 4,268 | 4,044 | $8K | |
| 82552 | 1,065 | 956 | $8K | |
| 87328 | 1,126 | 1,009 | $8K | |
| 87497 | 723 | 516 | $8K | |
| 80202 | 1,075 | 557 | $8K | |
| 82653 | 820 | 736 | $8K | |
| 82085 | 2,199 | 1,884 | $8K | |
| 87481 | 444 | 387 | $7K | |
| 83527 | 1,382 | 1,171 | $7K | |
| 84410 | 457 | 380 | $7K | |
| 86162 | 745 | 661 | $7K | |
| 84446 | 1,225 | 1,023 | $7K | |
| 83930 | 1,712 | 1,556 | $7K | |
| 82340 | 1,960 | 1,735 | $6K | |
| 82705 | 2,139 | 1,960 | $6K | |
| 83695 | 1,393 | 1,146 | $5K | |
| 85670 | 2,270 | 1,859 | $5K | |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | 11,524 | 10,361 | $5K |
| 83935 | 1,563 | 1,395 | $5K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 271 | 221 | $5K |
| 87106 | 878 | 802 | $5K | |
| 80367 | 6,107 | 5,796 | $5K | |
| 83014 | 1,248 | 1,131 | $5K | |
| 82610 | 678 | 613 | $5K | |
| 85049 | 2,152 | 1,843 | $5K | |
| 86357 | 255 | 219 | $5K | |
| 86747 | 343 | 303 | $5K | |
| G0472 | Hepatitis c antibody screening, for individual at high risk and other covered indication(s) | 8,115 | 6,904 | $5K |
| 85732 | 1,172 | 999 | $5K | |
| 81401 | 1,042 | 763 | $5K | |
| 87015 | 1,367 | 1,144 | $4K | |
| 87116 | 1,059 | 866 | $4K | |
| 81240 | 665 | 511 | $4K | |
| 87425 | 419 | 393 | $4K | |
| 80347 | 7,911 | 7,490 | $4K | |
| 86355 | 194 | 173 | $4K | |
| 84300 | 1,577 | 1,388 | $4K | |
| 84163 | 356 | 329 | $4K | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | 21,343 | 18,202 | $3K |
| 85303 | 562 | 464 | $3K | |
| 81383 | 105 | 72 | $3K | |
| 86036 | 677 | 563 | $3K | |
| 82172 | 3,587 | 2,857 | $3K | |
| G0306 | Complete cbc, automated (hgb, hct, rbc, wbc, without platelet count) and automated wbc differential count | 1,765 | 1,570 | $3K |
| 80356 | 689 | 624 | $3K | |
| 83835 | 374 | 344 | $3K | |
| 85300 | 590 | 477 | $3K | |
| 80337 | 5,693 | 5,387 | $3K | |
| 83874 | 514 | 441 | $3K | |
| 80370 | 7,867 | 7,462 | $3K | |
| 80338 | 5,695 | 5,390 | $3K | |
| 80368 | 5,722 | 5,416 | $3K | |
| 80360 | 5,711 | 5,406 | $2K | |
| 80334 | 5,703 | 5,397 | $2K | |
| 80377 | 5,679 | 5,375 | $2K | |
| 80235 | 367 | 325 | $2K | |
| 84252 | 262 | 173 | $2K | |
| 80326 | 5,671 | 5,364 | $2K | |
| 80364 | 5,667 | 5,363 | $2K | |
| 80341 | 5,667 | 5,362 | $2K | |
| 80331 | 5,667 | 5,362 | $2K | |
| 80371 | 5,670 | 5,365 | $2K | |
| 80344 | 5,680 | 5,375 | $2K | |
| 82668 | 381 | 311 | $2K | |
| 81517 | 32 | 30 | $2K | |
| 80366 | 5,686 | 5,381 | $2K | |
| 87254 | 218 | 201 | $2K | |
| 80357 | 5,664 | 5,359 | $2K | |
| 81490 | 268 | 234 | $2K | |
| 82542 | 221 | 178 | $2K | |
| 84152 | 251 | 224 | $2K | |
| 80320 | 179 | 170 | $2K | |
| 82232 | 404 | 359 | $2K | |
| 86631 | 294 | 266 | $2K | |
| 87420 | 213 | 203 | $2K | |
| 87807 | 216 | 208 | $2K | |
| 80355 | 5,659 | 5,359 | $2K | |
| 83003 | 226 | 195 | $2K | |
| 86880 | 717 | 629 | $2K | |
| 86005 | 608 | 510 | $2K | |
| 82180 | 391 | 279 | $2K | |
| 86753 | 233 | 181 | $1K | |
| 83625 | 213 | 188 | $1K | |
| 80369 | 347 | 342 | $1K | |
| 80201 | 305 | 280 | $1K | |
| 80362 | 430 | 422 | $1K | |
| 84145 | 194 | 172 | $1K | |
| 80230 | 79 | 58 | $1K | |
| 85305 | 228 | 191 | $1K | |
| 86148 | 360 | 192 | $981.39 | |
| 84202 | 102 | 98 | $978.87 | |
| 80198 | 133 | 127 | $925.62 | |
| 86738 | 58 | 52 | $907.84 | |
| 80203 | 177 | 161 | $830.65 | |
| 81015 | 640 | 581 | $785.36 | |
| 82308 | 52 | 43 | $696.43 | |
| 85302 | 150 | 129 | $676.31 | |
| 84597 | 98 | 76 | $650.41 | |
| 80145 | 73 | 66 | $637.27 | |
| 83937 | 41 | 32 | $574.21 | |
| 89060 | 133 | 122 | $548.36 | |
| 83631 | 149 | 128 | $536.95 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 72 | 67 | $528.15 |
| 88300 | 72 | 69 | $470.53 | |
| 84206 | 31 | 26 | $411.67 | |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 3,244 | 2,837 | $348.32 |
| G0123 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision | 1,113 | 1,015 | $318.41 |
| 86804 | 64 | 55 | $302.47 | |
| 89051 | 85 | 81 | $298.98 | |
| 85307 | 50 | 38 | $291.13 | |
| 86849 | 64 | 38 | $268.81 | |
| G0124 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician | 1,568 | 1,370 | $264.97 |
| 86215 | 49 | 38 | $255.49 | |
| 87230 | 28 | 25 | $253.69 | |
| 87476 | 18 | 17 | $246.17 | |
| 82384 | 35 | 28 | $243.04 | |
| 81283 | 13 | 13 | $232.34 | |
| 82681 | 41 | 27 | $228.35 | |
| 82175 | 21 | 18 | $226.25 | |
| 85046 | 44 | 43 | $183.69 | |
| 83825 | 21 | 18 | $180.15 | |
| 84181 | 81 | 61 | $168.55 | |
| 86703 | 40 | 26 | $136.35 | |
| 84133 | 52 | 50 | $128.32 | |
| 81256 | 15 | 13 | $118.86 | |
| 83986 | 56 | 51 | $117.25 | |
| 84140 | 20 | 18 | $113.74 | |
| 85705 | 32 | 24 | $103.75 | |
| 82595 | 47 | 44 | $98.48 | |
| 84433 | 17 | 13 | $97.84 | |
| 80342 | 14 | 12 | $94.19 | |
| 86790 | 37 | 27 | $90.26 | |
| 83605 | 20 | 15 | $85.37 | |
| 80323 | 12 | 12 | $84.89 | |
| 80158 | 32 | 25 | $68.35 | |
| 84591 | 20 | 17 | $43.28 | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 188 | 152 | $40.50 |
| 36416 | 6,062 | 5,588 | $26.15 | |
| S3600 | Stat laboratory request (situations other than s3601) | 4,029 | 3,234 | $17.74 |
| 99199 | Unlisted special service, procedure or report | 128 | 104 | $10.32 |
| 81002 | 1,328 | 851 | $6.75 | |
| 83698 | 38 | 24 | $0.00 | |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | 50 | 47 | $0.00 |
| P9603 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled | 492 | 480 | $0.00 |
| 99422 | 14 | 12 | $0.00 | |
| 80374 | 15 | 15 | $0.00 |